Full Text View
Tabular View
No Study Results Posted
Related Studies
Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214
This study has been withdrawn prior to enrollment.
( Sponsor decision to withdraw. )
Study NCT01500018   Information provided by AstraZeneca

First Received on December 6, 2011.   Last Updated on March 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Drug Abuse
Healthy
Additional conditions recognized in this trial
Substance-Related Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
TC-5214
TC-5214 Placebo
Ketamine
Phentermine
More general drug interventions related to this trial
Adrenergic Agents
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Anti-Obesity Agents
Appetite Depressants
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services